Growth Hormone Therapy and Bone Quality in Pediatric Osteoporosis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The primary objective of this study is to test the hypothesis that growth hormone, administered daily by subcutaneous injection for 2 years will result in a significantly greater BMD Z-score over optimal standard therapy.
Epistemonikos ID: 24fbeba019b67e949f987b676f94500a3fb4c089
First added on: May 05, 2024